Suicide plus immunogene therapy
Biologicalexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 13, 2017 (NCT03338777)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03338777 | Early Phase 1 (Phase 1) | Mar 13, 2017 | Government of Argentina, Hospital Italiano de Buenos Aires, National Council of Scientific and Technical Research, Argentina, University of Buenos Aires |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of Argentina | Government | 1 | 0 | 1 | 2017 |
| Hospital Italiano de Buenos Aires | Academic/Hospital | 1 | 1 | 1 | 2017 |
| National Council of Scientific and Technical Research, Argentina | Academic/Hospital | 1 | 0 | 1 | 2017 |
| University of Buenos Aires | Academic/Hospital | 1 | 0 | 1 | 2017 |
4 organizations
Page 1 / 1